Sydney, Mar 27, 2006 (ABN Newswire) - TISSUE THERAPIES LIMITED (ASX: TIS) - Small Caps Forum
Interview with Dr Stephen Mercer, CEO; Boardroomradio is pleased to announce that TISSUE THERAPIES LIMITED (ASX: TIS) has published an audio file. The following presentation "Interview with Dr Stephen Mercer, CEO" is now available as an instant audio download to your computer. You may also transfer this information to your listening device as an IPod podcast.
The BRR service is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider.
Broadcaster: TISSUE THERAPIES LIMITED (ASX: TIS)
Broadcast Title: Interview with Dr Stephen Mercer, CEO
Broadcast Type: Audio stream
View the Audio stream for TISSUE THERAPIES LIMITED (ASX: TIS) by clicking on the following links.
Display in Windows Media Player
http://www.boardroomradio.com/event/TIS/1308/8232/wmp/221.242.254.150/wsl.wmp?
or:
Display in MP3 Player or Transfer to Portable Podcast Device
http://www.boardroomradio.com/event/TIS/1308/8232/mp3/221.242.254.150/wsl.mp3?
Computers set up for access to the Internet, including at least a 28.8k modem and sufficient memory and hard disk space to run Windows Media Player or Real Player, should be able to run BRR media files.
About Boardroom Media
Boardroom.Media is a new breed of media company that's equal parts publisher, content producer, and streaming media technology business. With a strong footing in capital markets, professional services and asset management, the company has been a leading provider of multimedia communication solutions for corporate Australia for more than a decade.
About Factor Therapeutics Ltd
Factor Therapeutics Limited, formerly Tissue Therapies Limited, is a biotechnology company. The Company's principal activities include the development and commercialization of its intellectual property in wound care.
